Federal officials are removing a warning from treatments for menopause symptoms, they announced on Nov. 10.
Hormone replacement therapy, or estrogen treatments, will no longer warn women that taking the treatments can raise the risk of cardiovascular disease, breast cancer, and probable dementia, the Department of Health and Human Services (HHS), the parent agency of the Food and Drug Administration, said in a statement.
The FDA will work with companies that make the drugs to update language on labels for the products.
“We’re challenging outdated thinking and recommitting to evidence-based medicine that empowers rather than restricts,” Health Secretary Robert F. Kennedy Jr. said at a press conference in Washington announcing the move. “When prescribed responsibly and started early, hormone replacement therapy transforms the lives of women.”…